The late 1980s were heady days for molecular biologists. PCR was only a few years old. The automated DNA sequencer had just been invented. The Human Genome Project was being debated in Congress.
Subclinical acute rejection (SubAR) is a significant risk for kidney transplant recipients, affecting 1 in 4 patients. Early detection of SubAR can help prevent long-term allograft damage, including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results